Published in Methods on September 03, 2013
Microfluidic 3D models of cancer. Adv Drug Deliv Rev (2014) 0.84
Longitudinal, label-free, quantitative tracking of cell death and viability in a 3D tumor model with OCT. Sci Rep (2016) 0.75
Biodynamic imaging for phenotypic profiling of three-dimensional tissue culture. J Biomed Opt (2017) 0.75
Optical coherence tomography. Science (1991) 57.87
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods (2003) 18.51
Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography. Opt Lett (2003) 10.17
Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol (2006) 8.81
High-speed optical frequency-domain imaging. Opt Express (2003) 7.12
In vivo endoscopic optical biopsy with optical coherence tomography. Science (1997) 6.74
Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol (2006) 6.64
Optical coherence tomography for ultrahigh resolution in vivo imaging. Nat Biotechnol (2003) 5.29
Fourier Domain Mode Locking (FDML): A new laser operating regime and applications for optical coherence tomography. Opt Express (2006) 4.49
Self-regulation of growth in three dimensions. J Exp Med (1973) 2.87
Life isn't flat: taking cancer biology to the next dimension. In Vitro Cell Dev Biol Anim (2006) 2.32
Three-dimensional tissue culture models in cancer biology. Semin Cancer Biol (2005) 2.26
Three-dimensional cell cultures: from molecular mechanisms to clinical applications. Am J Physiol (1997) 2.17
Autocalibration of spectral-domain optical coherence tomography spectrometers for in vivo quantitative retinal nerve fiber layer birefringence determination. J Biomed Opt (2007) 2.01
Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of beta-catenin. J Cell Biol (1997) 1.60
Method for quantitative study of airway functional microanatomy using micro-optical coherence tomography. PLoS One (2013) 1.56
Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. Cancer Res (2010) 1.27
Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model. J Biomed Opt (2010) 1.25
Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT. PLoS One (2011) 1.22
In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment. Clin Cancer Res (2008) 1.20
In vitro ovarian tumor growth and treatment response dynamics visualized with time-lapse OCT imaging. Opt Express (2009) 1.11
The multilayered postconfluent cell culture as a model for drug screening. Crit Rev Oncol Hematol (2001) 1.11
Impact of extracellular acidity on the activity of P-glycoprotein and the cytotoxicity of chemotherapeutic drugs. Neoplasia (2006) 1.02
Modulation of growth and radiochemosensitivity of human malignant glioma cells by acidosis. Cancer (2002) 1.01
Bystander effects induced by diffusing mediators after photodynamic stress. Radiat Res (2009) 0.96
Novel application of multicellular layers culture for in situ evaluation of cytotoxicity and penetration of paclitaxel. Cancer Sci (2008) 0.93
Elemental tomography of cancer-cell spheroids reveals incomplete uptake of both platinum(II) and platinum(IV) complexes. J Am Chem Soc (2007) 0.91
In vitro optimization of EtNBS-PDT against hypoxic tumor environments with a tiered, high-content, 3D model optical screening platform. Mol Pharm (2012) 0.91
Label-Free, Longitudinal Visualization of PDT Response In Vitro with Optical Coherence Tomography. Isr J Chem (2012) 0.87
Establishment of human ovarian serous carcinomas cell lines in serum free media. Methods (2012) 0.85
Protein kinase C mediates cisplatin-induced loss of adherens junctions followed by apoptosis of renal proximal tubular epithelial cells. J Pharmacol Exp Ther (2004) 0.84